216 related articles for article (PubMed ID: 16410530)
1. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus.
Iikuni N; Okamoto H; Yoshio T; Sato E; Kamitsuji S; Iwamoto T; Momohara S; Taniguchi A; Yamanaka H; Minota S; Kamatani N
Ann Rheum Dis; 2006 Feb; 65(2):253-6. PubMed ID: 16410530
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
[TBL] [Abstract][Full Text] [Related]
3. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
5. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
6. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
[TBL] [Abstract][Full Text] [Related]
7. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
Ikenouchi-Sugita A; Yoshimura R; Okamoto T; Umene-Nakano W; Ueda N; Hori H; Katsuki A; Saito K; Tanaka Y; Nakamura J
World J Biol Psychiatry; 2010 Mar; 11(2):121-8. PubMed ID: 20109107
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
9. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
[TBL] [Abstract][Full Text] [Related]
10. [Expression of monocyte chemoattractant protein-1 and lupus nephritis].
Liu ZJ; Lin JY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):491-5. PubMed ID: 16178446
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
Lu XY; Ye S; Wang Y; Guo L; Chen XX; Fan W; Wang XD; Gu YY; Bao CD; Liu Q
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2462-6. PubMed ID: 17156673
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
Kozora E; Arciniegas DB; Filley CM; West SG; Brown M; Miller D; Grimm A; Devore MD; Wingrove C; Zhang L
Arthritis Rheum; 2008 Nov; 59(11):1639-46. PubMed ID: 18975359
[TBL] [Abstract][Full Text] [Related]
13. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
14. MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
Eisenkraft A; Keidan I; Bielorai B; Keller N; Toren A; Paret G
Leuk Res; 2006 Oct; 30(10):1259-61. PubMed ID: 16516290
[TBL] [Abstract][Full Text] [Related]
15. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
Bosma GP; Rood MJ; Zwinderman AH; Huizinga TW; van Buchem MA
Arthritis Rheum; 2000 Jan; 43(1):48-54. PubMed ID: 10643699
[TBL] [Abstract][Full Text] [Related]
16. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
[TBL] [Abstract][Full Text] [Related]
17. Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations.
Vogelgesang SA; Heyes MP; West SG; Salazar AM; Sfikakis PP; Lipnick RN; Klipple GL; Tsokos GC
J Rheumatol; 1996 May; 23(5):850-5. PubMed ID: 8724297
[TBL] [Abstract][Full Text] [Related]
18. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Takayama M; Yoshio T
Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
[TBL] [Abstract][Full Text] [Related]
19. Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis.
Grygorczuk S; Zajkowska J; Swierzbińska R; Pancewicz S; Kondrusik M; Hermanowska-Szpakowicz T
Rocz Akad Med Bialymst; 2005; 50():173-8. PubMed ID: 16358960
[TBL] [Abstract][Full Text] [Related]
20. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
Arinuma Y; Yanagida T; Hirohata S
Arthritis Rheum; 2008 Apr; 58(4):1130-5. PubMed ID: 18383393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
